Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy‐induced febrile neutropenia in children
2012
Population Pharmacokinetics of Liposomal Amphotericin B in Pediatric Patients with Malignant Diseases
2006
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
In vitro activity of a new triazole BAL4815, the active component of BAL8557 (the water-soluble prodrug), against Aspergillus spp.
2005
Galactomannan Antigenemia in Pediatric Oncology Patients With Invasive Aspergillosis
2008
Natural products: An evolving role in future drug discovery
2011 Standout
Prospective Aspergillus Galactomannan Antigen Testing in Pediatric Hematopoietic Stem Cell Transplant Recipients
2007
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
2002
Protein Oxidation in Aging, Disease, and Oxidative Stress
1997 Standout
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Necrotizing Enterocolitis: Review of State-of-the-Art Imaging Findings with Pathologic Correlation
2007
Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation
2010
Necrotizing Enterocolitis
2011 Standout
Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy
2008
Echinocandin antifungal drugs
2003 Standout
Emerging echinocandins for treatment of invasive fungal infections
2006
Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell's criteria?
2007
Voriconazole: A New Triazole Antifungal Agent
2003 Standout
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis
2004
Galactomannan Antigen Testing for Diagnosis of Invasive Aspergillosis in Pediatric Hematology Patients
2012
Free radical-mediated oxidation of free amino acids and amino acid residues in proteins
2003 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Recent trends and future prospects of socio-spatial differentiation in urban regions of Central and Eastern Europe: A lull before the storm?
2009 Standout
Combination Treatment of Invasive Fungal Infections
2005
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
[49] Determination of carbonyl content in oxidatively modified proteins
1990 Standout
Pharmacokinetics, Safety, and Tolerability of Voriconazole in Immunocompromised Children
2010
Regionale Polarisierung der demographischen Entwicklung in Ostdeutschland — Gleichwertigkeit der Lebensverhältnisse?
2007
Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia
2002
Regulation of Intracellular Protein Turnover: Covalent Modification as a Mechanism of Marking Proteins for Degradation
1986
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Stability of hexokinase II in Vitro and in ascites tumor cells
1982 StandoutNobel
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules
2006 Standout
Antifungal Activity and Pharmacokinetics of Posaconazole (SCH 56592) in Treatment and Prevention of Experimental Invasive Pulmonary Aspergillosis: Correlation with Galactomannan Antigenemia
2001
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Review and Update
2003 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
Enzyme inactivation via disulphide–thiol exchange as catalysed by a rat liver membrane protein
1980
Pharmacokinetics and Safety of Intravenous Voriconazole in Children after Single- or Multiple-Dose Administration
2004
Safety, Tolerability, and Pharmacokinetics of Micafungin (FK463) in Febrile Neutropenic Pediatric Patients
2005
Works of Helga Schmidt being referenced
Differences in the clinical and radiologic patterns of rotavirus and non-rotavirus necrotizing enterocolitis
1991
Five‐year‐survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long‐term survival
1999
Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis
2003
Aussagefähigkeit und Stellenwert von bildgebender Diagnostik und Duplexsonographie bei Neugeborenen mit nekrotisierender Enterokolitis
1994
Der Leipzig Atlas : unterwegs in einer weltoffenen Stadt am Knotenpunkt zwischen West- und Osteuropa
2005
Subcellular Distribution of a Factor Inactivating Tyrosine Aminotransferase
1978